5-54456136-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_006308.3(HSPB3):āc.347G>Cā(p.Arg116Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,614,102 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00024 ( 0 hom., cov: 32)
Exomes š: 0.00015 ( 1 hom. )
Consequence
HSPB3
NM_006308.3 missense
NM_006308.3 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 7.82
Genes affected
HSPB3 (HGNC:5248): (heat shock protein family B (small) member 3) This gene encodes a muscle-specific small heat shock protein. A mutation in this gene is the cause of autosomal dominant distal hereditary motor neuropathy type 2C.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 5-54456136-G-C is Benign according to our data. Variant chr5-54456136-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 353901.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BS2
High AC in GnomAd4 at 37 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152128Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
37
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251412Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135882
GnomAD3 exomes
AF:
AC:
60
AN:
251412
Hom.:
AF XY:
AC XY:
40
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461856Hom.: 1 Cov.: 53 AF XY: 0.000172 AC XY: 125AN XY: 727240
GnomAD4 exome
AF:
AC:
219
AN:
1461856
Hom.:
Cov.:
53
AF XY:
AC XY:
125
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000243 AC: 37AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74440
GnomAD4 genome
AF:
AC:
37
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
22
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
21
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Neuronopathy, distal hereditary motor, type 2C Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 12, 2018 | The HSPB3 c.347G>C; p.Arg116Pro variant (rs150931007) is reported in the literature in a single individual affected with myopathy and in her father, who was largely unaffected besides intermittent sciatic pain (Morelli 2017). The arginine at codon 116 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Studies of this variant in cultured cells indicate that it cannot interact with its binding partner HSPB2 and that it forms aggregates that may alter nuclear architecture. However, in the Genome Aggregation Database the p.Arg116Pro variant is found in the Ashkenazi Jewish population with an overall allele frequency of 0.39% (40/10148 alleles), which exceeds the estimated prevalence of the most common hereditary neuropathy, Charcot-Marie-Tooth disease, at 1 in 2500 (Barreto 2016). Due to conflicting information, the clinical significance of the p.Arg116Pro variant is uncertain at this time. References: Barreto LC et al. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. Neuroepidemiology. 2016;46(3):157-65. Morelli FF et al. Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function. Cell Rep. 2017 Aug 29;20(9):2100-2115. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at